ENO1 and breast carcinoma: Cell proliferation was evaluated by MTT assay after 24 h of treatment with 1% sera from MBP-1-ve or MBP-1+ve breast cancer patients, compared to 1% Foetal Bovin Serum (FBS) treatment.